The sections were stained with an anti-CD31 Ab revealing that both Del1-shRNA (Figure 4B), and VEGF-shRNA (Figure 4C) reduced tumor microvessel density by 28% and 35% (Figure 4E), respectively (both P < 0.05), compared with control (Figure 4A). This evidence concerns the gene PECAM1 and neoplasm.